A handful of hospitals and cancer clinics are tapping the cold calculations of AI to nudge conversations around some of the most deeply human questions. More
Carmen Quintero couldn't get a coronavirus test but ended up with a huge bill for trying to. She also was told to self-isolate and had no choice but to use vacation time to stay home from work. More
A 65-year-old man arrives from home to the emergency department by EMS with right-sided weakness beginning three hours prior. Advance neuroimaging demonstrates he does not qualify for endovascular clot retrieval. He has an NIHSS score of 11 and no contra-indications for systemic thrombolysis. More
The agency should take every measure to ensure the safety and efficacy of prescription drugs under emergency use authorization. More
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. More
This Medical News article is an interview with Chicago public health legend and retired physician Linda Rae Murray, MD, MPH, an adjunct assistant professor at the University of Illinois at Chicago School of Public Health and a past president of the American Public Health Association. More
COVID-19 has been redoubling the gaps in white privilege that have always existed. More
There’s another coronavirus. This one, causing horrific swelling in cats, even killing them. Gilead Pharmacueticals might have a drug that can cure this feline coronavirus. Yet, they’re not sharing that drug, possibly because they’re scared it might harm their chances with another drug: Remdesivir. You may have heard of it; it’s the supposed ‘gold standard’ of care for COVID-19. The story of Remdesivir (and of the black market cat drug sibling) reveals how pharmaceutical companies do their research, and the lengths they go to protect their profits. More
Three African American ER physicians in Washington, D.C., recount experiences on their wards, where Black patients make up the vast majority of the city's COVID-19 fatalities. More
When PPIs are indicated, they should be prescribed at the lowest dose and shortest time period. More
Mayo, in partnership with Medically Home, aims to deliver more affordable and efficient high-acuity care to patients typically bound to the hospital. More
The ways medical professionals try to protect their own families at home, while treating patients at work. More
The COVID-19 pandemic has revealed the inherent flaws in fee-for-service medicine. Congress should use healthcare’s current financial crisis to institute far-reaching changes in the reimbursement system. More
One core principle is that we cannot improve care if we do not examine our errors and use them to change our processes. Errors are destined to be repeated, and risk to patients further magnified when we do not learn from mistakes. More
The case is the latest inquiry into pharmaceutical companies’ donations to patient assistance charities, which have been blamed for inflating the cost of drugs. More
Inmates at Angola prison in Louisiana told ProPublica of widespread illness, dysfunctional care and deadly neglect as the coronavirus outbreak hit. More
Across the United States, and the world, health care workers are experiencing high levels of anxiety and stress due to the overwhelming workload of the COVID-19 pandemic. And those feelings of stress and anxiety can be compounded for Black health care workers. More
In the U.S., Black people have the highest rates of cancer-related deaths and the shortest survival with cancer of any racial and ethnic group. More
That study about dexamethasone has arrived with a big asterisk: While it appears to help severely ill patients, it harms others. More
Eating a healthy diet far outweighs the potential benefits of taking a supplement, experts say, and yet we have a whole industry based on selling us all types of products. Here's when to take one, after consulting with your doctor, and when to pass. More